General Sessions

Obama box 3-19-16.indd

To learn more about each of the Summit breakout sessions click on the title name (updated 3-25-16):
Monday
Welcoming Keynote
 
Tuesday
Opening General Session
Afternoon Keynote
Panel Discussion with President Obama
 
Wednesday
Opening General Session
Congressional Leaders Forum
Evening Keynote
Welcoming Keynote
Monday, March 28, 2016, 5:15 pm – 6:00 pm
Special Music Osborne_Dean-smDean Osborne
Director, Kentucky School of Bluegrass and Traditional Music, Hazard (KY) Community and Technical College
Presenter Vilsack_Tom-smTom Vilsack
Secretary of Agriculture, United States Department of Agriculture
 
 
Manchin_Joe-smHonorable Joseph “Joe” Manchin
United States Senator, State of West Virginia
 
 
Tomblin_EarlRay-smEarl Ray Tomblin, MBA
Governor, State of West Virginia
Session Description Our country’s drug problem is unique and requires a collaborative, all-hands-on-deck approach. Secretary Vilsack was recently charged by President Obama to lead the USDA’s new “Rural America Opioid Initiative,” a new interagency effort focused on addressing rural America’s struggles with heroin and opioid abuse. These efforts include addressing the 76 percent shortage of mental illness and substance abuse services in rural areas. Overdose deaths in the United States continue to increase, driven in large part by sharp spikes in heroin deaths and an emerging increase in deaths involving illicit synthetic opioids. According to the CDC, 45 percent of people who had used heroin were also addicted to prescription opioid painkillers. Secretary Vilsack, who has experienced the impact of addiction within his own family, will discuss the strategies to be taken through this new initiative.

Following this presentation, West Virginia Senator Joe Manchin and West Virginia Governor Earl Ray Tomblin will join Secretary Vilsack for a panel discussion. Last year, West Virginia hosted a Town Hall meeting with President Barack Obama where a number of new public and private sector actions to address the epidemic were announced.

Return to the top
Opening General Session
Tuesday, March 29, 2016, 9:00 am – 11:00 pm
Special Music Osborne_Dean-smDean Osborne
Director, Kentucky School of Bluegrass and Traditional Music, Hazard (KY) Community and Technical College
Presenters Rogers_Hal-smHonorable Harold “Hal” Rogers
United States Representative, R-Kentucky 5th District, Chair, Committee on Appropriations
 
Botticelli_Michael-smMichael P. Botticelli
Director, White House Office of National Drug Control Policy
 
 
Califf_Robert-official-smRobert M. Califf, MD, MACC
Commissioner, United States Food and Drug Administration
 
 
Dr. Francis S. Collins, Director of NIH.Francis S. Collins, MD, PhD
Director, National Institutes of Health
 
 
Enomoto_Kana-smKana Enomoto
Acting Administrator, Substance Abuse and Mental Health Services Administration
Session Description For 35 years, Congressman Hal Rogers has served in a number of leadership roles. He currently serves as Chairman of the House Committee on Appropriations, co-founded the bipartisan Congressional Caucus on Prescription Drug Abuse, established a competitive grant program to assist state-level Prescription Drug Monitoring Programs, and has directed funding for marijuana eradication. Congressman Rogers received the 2016 National Leadership Award from the Community Anti-Drug Coalitions of America in recognition of the significant contributions he has made to the field of substance abuse prevention and long-standing support of community-based drug prevention.

Michael Botticelli brings more than two decades of experience supporting Americans who have been affected by substance use disorders. As the White House’s top law enforcement executive, he is responsible for coordinating efforts to reduce Rx drug abuse, heroin use and related overdoses through initiatives outlined in the National Drug Control Strategy. Director Botticelli is tasked with reducing drug use and its consequences through increased support for community-based prevention efforts, prescriber and public education, law enforcement responses, and recovery support services.

Dr. Robert Califf was named Commissioner of the U.S. Food and Drug Administration in February 2016. In this role, he is responsible for strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health. He previously served as the FDA’s Deputy Commissioner for Medical Products and Tobacco A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science.

Dr. Francis Collins directs the National Institutes of Health. He plays an active role in setting policy, planning, managing and coordinating programs and activities for each of the 27 different institutes and centers within the NIH. In addition, with a unique and critical perspective on the organization as a whole, he is responsible for identifying needs and opportunities. A physician-geneticist, Dr. Collins is noted for his landmark discoveries of disease genes and his leadership on the international Human Genome Project.

Kana Enomoto is Acting Administrator of SAMHSA, the agency within the U.S. Department of Health and Human Services that leads public health efforts to reduce the impact of substance abuse and mental illness on America’s communities. Last year alone, approximately 20 million people in need of substance abuse treatment did not receive it. Further, an estimated 10.6 million people reported an unmet need for mental health care. Ms. Enomoto will discuss why it is important to address this gap in service.

Return to the top
Afternoon Keynote
Tuesday, March 29, 2016, 1:15 pm – 2:00 pm
Special Music Osborne_Dean-smDean Osborne
Director, Kentucky School of Bluegrass and Traditional Music, Hazard (KY) Community and Technical College
Host Taylor_MarciaLee-smMarcia Lee Taylor
President and CEO, Partnership for Drug-Free Kids
Presenter Murthy_DrVivek-smVice Admiral Vivek H. Murthy, MD, MBA
United States Surgeon General
Session Description Dr. Vivek Murthy is “America’s Doctor,” responsible for communicating the best available scientific information to the public regarding ways to improve personal health and the health of the nation. He has served as Surgeon General since December 2014. He also oversees the operations of the U.S. Public Health Service Commissioned Corps, comprised of approximately 6,700 uniformed health officers who serve around the world to promote, protect, and advance the health and safety of our country.
Return to the top
Panel Discussion with President Obama
Tuesday, March 29, 2016, 2:30 pm – 3:45 pm
Presenter Obama_Barack-official-smBarack H. Obama
President of the United States of America
Session Description United States President Barack Obama will participate in a Panel Dicussion on administration’s efforts to address the Rx drug abuse and heroin epidemics.
Return to the top
Morning General Session
Wednesday, March 30, 2016, 8:00 am – 9:15 am
Special Music Osborne_Dean-smDean Osborne
Director, Kentucky School of Bluegrass and Traditional Music, Hazard (KY) Community and Technical College
Host Capilouto_Eli-smEli Capilouto, ScD
President, University of Kentucky
Presenters Volkow_Nora-smNora D. Volkow, MD
Director, National Institute on Drug Abuse
 
 
Frieden_Tom-sm copyTom Frieden, MD, MPH
Director, Centers for Disease Control and Prevention
Session Description Drug overdose deaths involving prescription opioid pain relievers have increased dramatically since 1999. Concerted federal and state efforts have been made to curb this epidemic. An interagency strategy released in 2011 that included educating providers, pharmacists, patients, parents and youth about the dangers of Rx drug abuse and the need for proper prescribing, dispensing, use and disposal; implementing effective prescription drug monitoring programs; facilitating proper medication disposal; and supporting aggressive enforcement to address doctor shopping and pill mills and support development of abuse-resistance formulations for opioid pain relievers.

Some success has been seen. Since 2007, however, overdose deaths related to heroin have started to increase. The Centers for Disease Control and Prevention counted 10,574 heroin overdose deaths in 2014, which represents more than a fivefold increase of the heroin death rate from 2002 to 2014. Last March, the Secretary of Health and Human Services announced an initiative to reduce addiction and mortality related to opioid abuse.

Research by the National Institute on Drug Abuse (NIDA) and aggressive efforts by the Centers for Disease Control and Prevention (CDC) are making inroads to address this complex problem. Citizens have become more engaged in prevention and treatment efforts, while science is offering promising new approaches that will save lives and hopefully reverse the alarming statistics.

During this session – moderated by University of Kentucky President Eli Capilouto – Dr. Frieden and Dr. Volkow will each provide an update on the accomplishments of their respective agencies since last year’s Summit and discuss new challenges expected in the future. Following their remarks, they will answer questions from the audience. Please prepare your questions and hand them to a staff member when directed.

Return to the top
Congressional Leaders Forum
Wednesday, March 30, 2016, 9:30 am – 11:30 am
Moderator Edwards_Doug-smDouglas J. Edwards, MBA
Vice President and Managing Director, Behavioral Healthcare Division, Vendome Group, LLC
Presenters Markey_Ed-smHonorable Edward J. Markey, JD
United States Senator, D-Commonwealth of Massachusetts
 
 
Carter_Earl-smHonorable Earl L. “Buddy” Carter
United States Representative, R-Georgia, 1st District
 
 
Gosar_Paul-smHonorable Paul A. Gosar, DDS
United States Representative, R-Arizona, 4th District
 
 
Guinta_Frank-smHonorable Frank C. Guinta, LLM
United States Representative, R-New Hampshire, 1st District
 
 
Jenkins_Evan-official-smHonorable Evan Jenkins, JD
United States Representative, R-West Virginia, 3rd District, Member, Congressional Caucus on Prescription Drug Abuse
 
 
Keating_Bill-smHonorable William R. “Bill” Keating
United States Representative, D-Massachusetts, 9th District, and Member, Congressional Caucus on Prescription Drug Abuse
 
Rogers_Hal-smHonorable Harold “Hal” Rogers
United States Representative, R-Kentucky, 5th District, Chair, Committee on Appropriations, and Founding Co-Chair, Congressional Caucus on Prescription Drug Abuse
Session Description This bipartisan panel is comprised of legislators who are working to raise awareness of Rx abuse and heroin use and to bring innovative and effective policy solutions to Congress. There have been several positive accomplishments in the past year, including passage of the “Protecting Our Infants Act,” creation of a Senate Caucus on Prescription Drug Abuse, and launch of Congress’ Bipartisan Task Force to Combat the Heroin Epidemic. This Forum will include presentations from each of the Congressional members, including the Co-Founder and Co-Chair of the House Congressional Caucus on Prescription Drug Abuse, about what is occurring in Washington that can make a positive impact. Panelists will address their legislative priorities and provide updates on current legislation – such as the “Promoting Responsible Opioid Prescribing (PROP) Act” that eliminate a potential penalty on physicians who refuse to over-prescribe powerful painkillers, and the “Stop the Overuse Problem Already Becoming a Universal Substance Epidemic (STOP ABUSE) Act” that presents a comprehensive approach to treating and stopping the heroin epidemic.
Return to the top
Evening Keynote
Wednesday, March 30, 2016, 5:00 pm – 6:00 pm
Presenters Rosenberg_Chuck-smChuck Rosenberg, MPP, JD
Acting Administrator, United States Drug Enforcement Administration
Session Description The motto of the United States Drug Enforcement Administration (DEA) is: “Tough work. Vital mission.” As Acting Administrator, Chuck Rosenberg is responsible for enforcing our country’s controlled substances laws and regulations. It is also his department’s mission to support non-law enforcement programs aimed at reducing the availability of controlled substances. Mr. Rosenberg will discuss how the DEA carries out its responsibilities, which include: investigation and preparation for prosecution of major violators operating at interstate and international levels; enforcement of the provisions of the Controlled Substances Act as they pertain to the manufacture, distribution and dispensing of legally produced controlled substances; and coordinating with local, state and federal law enforcement officials to enhance such efforts.
Return to the top
The content and scheduled times of these Summit General Sessions are subject to change.